Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
21/04/2026 07:38
April 21 (Reuters) - Elicera Therapeutics AB ELIC.ST: ELICERA THERAPEUTICS CARRIES OUT A RIGHTS ISSUE OF APPROXIMATELY SEK 73 MILLION SUBSCRIPTION PERIOD FOR RIGHTS ISSUE RUNS FROM 15 MAY TO 29 MAY 2026 SECURED AMOUNT EXPECTED TO FINANCE OPERATIONS UNTIL END OF 2028 SUBSCRIPTION PRICE IN RIGHTS ISSUE IS SEK 3.0 PER SHARE RIGHTS ISSUE COMPRISES A MAXIMUM OF 24,267,772 NEW SHARES Source text: ID:nWkrbtP0rL Further company coverage: ELIC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Nomination Committee Proposes Margareth Jorvid As Chair Of Elicera Board
Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
Sweden's Elicera Therapeutics Q1 loss narrows, reports positive clinical progress
Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent